CAH's specialty growth, strong pharma demand and expanding services portfolio are driving earnings momentum and positioning ...
CAH expands Ac-225 capacity, boosting its role in radiopharma as rising clinical demand and future cancer therapy ...
Zacks.com on MSN
Can CAH's Specialty Flywheel Strategy Unlock Long-Term Growth?
Cardinal Health’s CAH evolving “specialty flywheel” strategy is emerging as a powerful engine for long-term growth, driven by the integration of distribution, MSO platforms and biopharma services into ...
Zacks Investment Research on MSN
Are GLP-1 drugs becoming a meaningful revenue driver for CAH stock?
Cardinal Health CAH is clearly benefiting from the rapid adoption of GLP-1 therapies, though the impact remains more pronounced on revenues than profitability. In the second quarter of fiscal 2026, ...
Bengaluru (Karnataka) [India], April 11: The Leadership Federation successfully concluded its flagship leadership gathering on 7th & 8th April 2026 in Bengaluru, bringing together some of the most ...
A new report from BCC Research finds that the global market for infusion pumps and devices will grow from $9.0 billion in ...
Telix’s ( ASX:TLX) March-quarter precision medicine sales grew 16% on December 2025 to USD 186 million. Total revenue was USD ...
Congress largely preserved federal funding for biomedical and public health research, but researchers and University of Wisconsin-Madison officials say the damage is already done.
One person died and a second person was hurt in a shooting at the First Stop Bar and Grill along Oakland Park Avenue in the ...
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the European launch of its BD Pyxis Pro ...
As Aussies turn to stockpiling fuel amid the petrol crisis, a Drive investigation reveals ...
A fierce debate has erupted online after a Sydney woman took aim at the “rude” etiquette of her fellow public transport users ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results